RT Journal Article
T1 Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network.
A1 López-Guerrero, José Antonio
A1 Mendiola, Marta
A1 Pérez-Fidalgo, José Alejandro
A1 Romero, Ignacio
A1 Torres, Ana
A1 Recalde, Delia
A1 Molina, Elena
A1 Gómez-Raposo, César
A1 Levin, Ana M
A1 Herrero, Ana
A1 Alarcón, Jesús
A1 Esteban, Carmen
A1 Marquina, Gloria
A1 Rubio, María Jesús
A1 Guerra, Eva
A1 Sánchez-Lorenzo, Luisa
A1 Gálvez-Montosa, Fernando
A1 de Juan, Ana
A1 Churruca, Cristina
A1 Gallego, Alejandro
A1 González-Martín, Antonio
K1 biobanking
K1 biospecimens
K1 gynaecological cancer
K1 harmonisation
K1 patient registry
K1 translational research
AB Patient registries linked to biorepositories constitute a valuable asset for clinical and translational research in oncology. The Spanish Group of Ovarian Cancer Research (GEICO), in collaboration with the Spanish Biobank Network (RNBB), has developed a multicentre, multistakeholder, prospective virtual clinical registry (VCR) associated with biobanks for the collection of real-world data and biological samples of gynaecological cancer patients. This collaborative project aims to promote research by providing broad access to high-quality clinical data and biospecimens for future research according to the needs of investigators and to increase diagnostic and therapeutic opportunities for gynaecological cancer patients in Spain. The VCR will include the participation of more than 60 Spanish hospitals entering relevant clinical information in harmonised electronic case report forms (eCRFs) in four different cohorts: ovarian, endometrial, cervical, and rare gynaecological cancers (gestational trophoblastic disease). Initial data for the cases included till December 2021 are presented. The model described herein establishes a real-world win-win collaboration between multicentre structures, promoted and supported by GEICO, that will contribute to the success of translational research in gynaecological cancer.
SN 2072-6694
YR 2022
FD 2022-04-13
LK http://hdl.handle.net/10668/20885
UL http://hdl.handle.net/10668/20885
LA en
DS RISalud
RD Apr 9, 2025